These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


258 related items for PubMed ID: 24833735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early Onset Ultrastructural and Functional Defects in RPE and Photoreceptors of a Stargardt-Like Macular Dystrophy (STGD3) Transgenic Mouse Model.
    Kuny S, Cho WJ, Dimopoulos IS, Sauvé Y.
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7109-21. PubMed ID: 26529045
    [Abstract] [Full Text] [Related]

  • 3. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
    Barabas P, Liu A, Xing W, Chen CK, Tong Z, Watt CB, Jones BW, Bernstein PS, Križaj D.
    Proc Natl Acad Sci U S A; 2013 Mar 26; 110(13):5181-6. PubMed ID: 23479632
    [Abstract] [Full Text] [Related]

  • 4. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
    Logan S, Agbaga MP, Chan MD, Kabir N, Mandal NA, Brush RS, Anderson RE.
    Proc Natl Acad Sci U S A; 2013 Apr 02; 110(14):5446-51. PubMed ID: 23509295
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration.
    Sommer JR, Estrada JL, Collins EB, Bedell M, Alexander CA, Yang Z, Hughes G, Mir B, Gilger BC, Grob S, Wei X, Piedrahita JA, Shaw PX, Petters RM, Zhang K.
    Br J Ophthalmol; 2011 Dec 02; 95(12):1749-54. PubMed ID: 21873315
    [Abstract] [Full Text] [Related]

  • 10. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes.
    Vasireddy V, Vijayasarathy C, Huang J, Wang XF, Jablonski MM, Petty HR, Sieving PA, Ayyagari R.
    Mol Vis; 2005 Aug 30; 11():665-76. PubMed ID: 16163264
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.
    Vasireddy V, Jablonski MM, Khan NW, Wang XF, Sahu P, Sparrow JR, Ayyagari R.
    Exp Eye Res; 2009 Dec 30; 89(6):905-12. PubMed ID: 19682985
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term retinal cone survival and delayed alteration of the cone mosaic in a transgenic mouse model of stargardt-like dystrophy (STGD3).
    Kuny S, Filion MA, Suh M, Gaillard F, Sauvé Y.
    Invest Ophthalmol Vis Sci; 2014 Jan 21; 55(1):424-39. PubMed ID: 24334447
    [Abstract] [Full Text] [Related]

  • 16. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
    Barabas P, Gorusupudi A, Bernstein PS, Krizaj D.
    Adv Exp Med Biol; 2016 Jan 21; 854():137-43. PubMed ID: 26427404
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability.
    Karan G, Yang Z, Zhang K.
    Mol Vis; 2004 Mar 31; 10():248-53. PubMed ID: 15073583
    [Abstract] [Full Text] [Related]

  • 20. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
    Schori C, Agbaga MP, Brush RS, Ayyagari R, Grimm C, Samardzija M.
    PLoS One; 2018 Mar 31; 13(1):e0190514. PubMed ID: 29293603
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.